NEW YORK (GenomeWeb News) – China's Ministry of Commerce has approved Thermo Fisher's $15.8 billion acquisition of Life Technologies, pending the divestiture of Thermo Fisher's cell culture business and several other conditions.

In addition to the sale of the cell culture business, the Ministry of Commerce has asked Thermo Fisher to sell its stake in Lanzhou National Hyclone Bio-engineering Co., to divest its gene modulation business, and to reduce the price of its SSP kits and SDS-PAGE protein standards in the Chinese market.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

In Nature this week: omic analysis of permafrost microbes, hookworm genome, and more.

Biologists turn to environmental DNA sampling to determine whether elusive or invasive species are shedding DNA in a given area.

Rob Knight writes at Scientific American that microbiome studies are about to break out of the laboratory.

Harold Varmus, the director of the National Cancer Institute, has announced that he is stepping down after nearly five years.